Introduction
Antithrombin Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. Antithrombin is a type of protein found in human blood which act as a natural blood thinner and thus, plays an important role in prevention of blood clotting. It is extensively used during the surgeries for the patient with low antithrombin levels. As per the research studies, by 2030 one person in every six people will live 65 and hardly above, which clearly mentions the unhealthy lifestyle and short life spam of people in the upcoming decades. The risk for cardiovascular diseases will increase and so the antithrombin market will have the growth.
The global antithrombin market is primarily driven by the widespread use of antithrombin for the treatment of several medical conditions such hereditary deficiency of antithrombin deficiency, extracorporeal membrane oxygenation, disseminated intravascular coagulation, and sepsis. The increasing use of antithrombin twined with heparin is likely to open extremely great opportunities for this market.
“Therapeutics is the most attractive application typeâ€
In 2019, the therapeutics application segment accounted a market share of 95.7%. By source goat milk
Geographical Overview
Asia-Pacific is more likely to be the fastest growing region in the market during the forecasted period, which accounted for USD 190 million in 2019. Also Europe holds a high potential for the growth of this market. This is attributed due to the growing familiarity of the antithrombin III deficiency amongst the population. Key factors such as changing eating habits, fast lifestyle and increasing risk of the diseases and also the awareness about the same driven the rise in the growth of the antithrombin market. North America, and the Latin America are also major regions in the global antithrombin market.
Segmental Overview
Antithrombin Market is segmented as per below specifications -
By Application:
• Therapeutics
• Research
• Diagnostics
By Source:
• Human
• Goat milk
• Others
By Dosage form:
• Lyophilized
• Liquid
Competitor Analysis
Antithrombin Market has presence of some of the key major players across globe which includes
• Grifols
• LFB USA
• Shire Plc.
• CSL Ltd.
• Kedrion S.P.A.
• Octapharma AG
• Lee Biosolutions
• Scripps Laboratories
• Diapharma Group Inc.
These key players are concentratingits efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share,companies are adoptingmerger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is Antithrombin Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by leadingPlayers
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 Antithrombin Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis
Global Antithrombin Market Estimation and Forecast, 2017 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia& CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 Grifols
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 LFB USA
6.3 Shire Plc.
6.4 CSL Ltd.
6.5 Kedroin S.P.A
6.6 Octapharma AG
6.7 Lee Biosolutions
6.8 Scripps Laboratories
6.9 Diapharma Group Inc.
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 12 Companies
Chapter 8 Global Antithrombin Market by Application Type Estimation and Forecast, 2017 - 2025 (USD Billion)
8.1 Therapeutics
8.2 Research
8.3 Diagnostics
Chapter 9 Global Antithrombin Market by Source Type Estimation and Forecast, 2017 - 2025 (USD Billion)
9.1 Human
9.2 Goat Milk
Chapter 10 Global Antithrombin Market by Dosage Form Channel Estimation and Forecast, 2017 - 2025 (USD Billion)
10.1 Lyophilized
10.2 Liquid
Chapter 11 Appendix
11.1 Data Sources
11.2 Abbreviations
11.3 About US
11.4 Disclaimer
11.5 Key Notes
List of Tables
Table 1 Global Antithrombin Market, by Region, 2017 - 2025 (USD Billion)
Table2 Global Antithrombin Market, by Product Type, 2017 - 2025 (USD Billion)
Table3 Global Antithrombin Market, by Consumption Type, 2017 - 2025 (USD Billion)
Table4 Global Antithrombin Market, by Distribution Type, 2017 - 2025 (USD Billion)
Table5North America Antithrombin Market2017 - 2025 (USD Billion)
Table6North America Antithrombin Market by Product Type 2017 - 2025 (USD Billion)
Table7North America Antithrombin Market by Consumption Type 2017 - 2025 (USD Billion)
Table8North America Antithrombin Market by Distribution Type 2017 - 2025 (USD Billion)
Table9US Antithrombin Market2017 - 2025 (USD Billion)
Table10Canada Antithrombin Market2017 - 2025 (USD Billion)
Table11Europe Antithrombin Market2017 - 2025 (USD Billion)
Table12Europe Antithrombin Market by Product Type 2017 - 2025 (USD Billion)
Table13Europe Antithrombin Market by Consumption Type 2017 - 2025 (USD Billion)
Table14Europe Antithrombin Market by Distribution Type 2017 - 2025 (USD Billion)
Table15 UK Antithrombin Market2017 - 2025 (USD Billion)
Table16GermanyAntithrombin Market2017 - 2025 (USD Billion)
Table17France Antithrombin Market2017 - 2025 (USD Billion)
Table18Spain Antithrombin Market2017 - 2025 (USD Billion)
Table19ItalyAntithrombin Market2017 - 2025 (USD Billion)
Table20Russia& CISAntithrombin Market2017 - 2025 (USD Billion)
Table21Rest of Europe Antithrombin Market2017 - 2025 (USD Billion)
Table22Asia Pacific Antithrombin Market2017 - 2025 (USD Billion)
Table23Asia Pacific Antithrombin Market by Product Type 2017 - 2025 (USD Billion)
Table24Asia Pacific Antithrombin Market by Consumption Type 2017 - 2025 (USD Billion)
Table25Asia Pacific Antithrombin Market by Distribution Type 2017 - 2025 (USD Billion)
Table26ChinaAntithrombin Market2017 - 2025 (USD Billion)
Table27Japan Antithrombin Market2017 - 2025 (USD Billion)
Table28IndiaAntithrombin Market2017 - 2025 (USD Billion)
Table29South KoreaAntithrombin Market2017 - 2025 (USD Billion)
Table30ASEAN Antithrombin Market2017 - 2025 (USD Billion)
Table31Rest of Asia Pacific Antithrombin Market2017 - 2025 (USD Billion)
Table32Latin America Antithrombin Market2017 - 2025 (USD Billion)
Table33Latin America Antithrombin Market by Product Type 2017 - 2025 (USD Billion)
Table34Latin America Antithrombin Market by Consumption Type 2017 - 2025 (USD Billion)
Table35Latin America Antithrombin Market by Distribution Type 2017 - 2025 (USD Billion)
Table36 Brazil Antithrombin Market2017 - 2025 (USD Billion)
Table37 Argentina Antithrombin Market2017 - 2025 (USD Billion)
Table38 Rest of Latin America Antithrombin Market2017 - 2025 (USD Billion)
Table39Middle EastAntithrombin Market2017 - 2025 (USD Billion)
Table40 Middle East Antithrombin Market by Product Type 2017 - 2025 (USD Billion)
Table41Middle East Antithrombin Market by Consumption Type 2017 - 2025 (USD Billion)
Table42Middle East Antithrombin Market by Distribution Type 2017 - 2025 (USD Billion)
Table43Africa Antithrombin Market2017 - 2025 (USD Billion)
Table44 Africa Antithrombin Market by Product Type 2017 - 2025 (USD Billion)
Table45Africa Antithrombin Market by Consumption Type 2017 - 2025 (USD Billion)
Table46Africa Antithrombin Market by Distribution Type 2017 - 2025 (USD Billion)
List of Figures
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 Antithrombin Market: Penetration & growth prospect mapping
Fig. 8 Antithrombin Market: Competitive snapshot
Fig. 9 Antithrombin Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 Antithrombin Market: Product Analysis, 2017- 2025
Fig. 12 Antithrombin Market: Regional Analysis, 2017- 2025
Fig. 13 Antithrombin Market: Competitive Matrix
Fig. 14 Antithrombin Market: Revenue Mix